IL17A and myocardial ischemia: Studies have shown that during MIRI, IL-17, as a special pro-inflammatory cytokine, participates in the occurrence of myocardial ischemia-re-perfusion injury by promoting cardiomyocyte apoptosis, recruiting neutrophil infiltration, and leading to myocardial remodeling, and is closely related to the pathogenesis of various cardiovascular diseases (92–94).